<VariationArchive VariationID="387" VariationName="NM_000308.4(CTSA):c.517_518del (p.Phe173fs)" VariationType="Deletion" Accession="VCV000000387" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2015-04-18" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15426" VariationID="387">
      <GeneList>
        <Gene Symbol="CTSA" FullName="cathepsin A" GeneID="5476" HGNC_ID="HGNC:9251" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="45891335" stop="45898820" display_start="45891335" display_stop="45898820" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="44519590" stop="44527458" display_start="44519590" display_stop="44527458" Strand="+" />
          </Location>
          <OMIM>613111</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000308.4(CTSA):c.517_518del (p.Phe173fs)</Name>
      <CanonicalSPDI>NC_000020.11:45892794:TTTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="45892795" stop="45892796" display_start="45892795" display_stop="45892796" variantLength="2" positionVCF="45892794" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="44521434" stop="44521435" display_start="44521434" display_stop="44521435" variantLength="2" positionVCF="44521433" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F173fs</ProteinChange>
      <ProteinChange>F156fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000308.3" sequenceAccession="NM_000308" sequenceVersion="3" change="c.571_572delTT">
            <Expression>NM_000308.3:c.571_572delTT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.44521436_44521437del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.44521436_44521437del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.45892797_45892798del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.45892797_45892798del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008291.1" sequenceAccession="NG_008291" sequenceVersion="1" change="g.6846_6847del">
            <Expression>NG_008291.1:g.6846_6847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033108.1" sequenceAccession="NG_033108" sequenceVersion="1" change="g.3492_3493del">
            <Expression>NG_033108.1:g.3492_3493del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000308.4" sequenceAccession="NM_000308" sequenceVersion="4" change="c.517_518del" MANESelect="true">
            <Expression>NM_000308.4:c.517_518del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000299.3" sequenceAccession="NP_000299" sequenceVersion="3" change="p.Phe173fs">
            <Expression>NP_000299.3:p.Phe173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127695.3" sequenceAccession="NM_001127695" sequenceVersion="3" change="c.517_518del">
            <Expression>NM_001127695.3:c.517_518del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121167.1" sequenceAccession="NP_001121167" sequenceVersion="1" change="p.Phe173fs">
            <Expression>NP_001121167.1:p.Phe173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167594.3" sequenceAccession="NM_001167594" sequenceVersion="3" change="c.466_467del">
            <Expression>NM_001167594.3:c.466_467del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161066.2" sequenceAccession="NP_001161066" sequenceVersion="2" change="p.Phe156fs">
            <Expression>NP_001161066.2:p.Phe156fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_133656.2" sequenceAccession="NR_133656" sequenceVersion="2" change="n.562_563del">
            <Expression>NR_133656.2:n.562_563del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000308.4" sequenceAccession="NM_000308" sequenceVersion="4" change="c.517_518delTT" MANESelect="true">
            <Expression>NM_000308.4:c.517_518delTT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212738" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="613111.0013" DB="OMIM" />
        <XRef Type="rs" ID="769812697" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9603439 Fig. 2b determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000308.4(CTSA):c.517_518del (p.Phe173fs) AND Galactosialidosis, late infantile" Accession="RCV000000418" Version="5">
        <ClassifiedConditionList TraitSetID="101">
          <ClassifiedCondition DB="MedGen" ID="C4017292">Galactosialidosis, late infantile</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000308.4(CTSA):c.517_518del (p.Phe173fs) AND Combined deficiency of sialidase AND beta galactosidase" Accession="RCV001526984" Version="5">
        <ClassifiedConditionList TraitSetID="103">
          <ClassifiedCondition DB="MedGen" ID="C0268233">Combined deficiency of sialidase AND beta galactosidase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-04-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-06" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-04-18" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10571006</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15110321</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28603679</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29876240</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9603439</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="101" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9633" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Galactosialidosis, late infantile</ElementValue>
              </Name>
              <XRef ID="C4017292" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="103" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5174" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Goldberg syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neuraminidase deficiency with beta-galactosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal protective protein deficiency of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Protective protein/Cathepsin A deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cathepsin A deficiency of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neuraminidase/beta-galactosidase expression</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CATHEPSIN A DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="256540" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Combined deficiency of sialidase AND beta galactosidase</ElementValue>
                <XRef ID="Combined+deficiency+of+sialidase+AND+beta+galactosidase/8009" DB="Genetic Alliance" />
                <XRef ID="35691006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosialidosis</ElementValue>
                <XRef ID="MONDO:0009737" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSL</ElementValue>
                <XRef Type="MIM" ID="256540" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NGBE</ElementValue>
                <XRef Type="MIM" ID="256540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3953" />
                <XRef ID="3953" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="351" DB="Orphanet" />
              <XRef ID="C0268233" DB="MedGen" />
              <XRef ID="MONDO:0009737" DB="MONDO" />
              <XRef Type="MIM" ID="256540" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20562" SubmissionDate="2021-06-25" DateLastUpdated="2021-07-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613111.0013_GALACTOSIALIDOSIS, LATE INFANTILE" title="CTSA, 2-BP DEL, 517TT_GALACTOSIALIDOSIS, LATE INFANTILE" />
        <ClinVarAccession Accession="SCV000020562" DateUpdated="2021-07-07" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with the late infantile form of galactosialidosis (GSL; 256540), Richard et al. (1998) identified compound heterozygosity for 2 mutations in the CTSA gene: a 2-nucleotide deletion, 517_518delTT, and an intronic mutation, IVS8+9C-G (613111.0015), resulting in abnormal splicing and a 5-nucleotide insertion in the CTSA cDNA. Both mutations caused frameshifts and resulted in the synthesis of truncated cathepsin A proteins, which, as suggested by structural modeling, are incapable of dimerization, complex formation, and catalysis. However, study of the patient's cultured skin fibroblast extracts suggested that a small amount of cathepsin A mRNA was spliced normally and produced the wildtype protein. This may have contributed to the relatively mild phenotype of the patient. The patient was an 18-year-old woman whose father and mother were healthy and nonconsanguineous, of Polish and Italian-Canadian origin, respectively. At 7 months of age she had shown mild hepatosplenomegaly, respiratory obstruction, bilateral lamellar cataracts, and bone changes including atypical punctate calcifications of the tarsal region. She walked at 21 months, was fitted with hearing aids at 3 years of age, and spoke with good sentences at the age of 4.5 years. She retained functional vision despite mild myopia, lamellar cataracts, mild corneal opacification and bilateral macular cherry red spots, perifoveal hypopigmentation, and tortuosity of the retinal arteries. Progressive hyperreflexia was first noted at 3 years of age and intention myoclonus at 9 years of age. At age 12, CT scan showed cerebral atrophy. EEG at 16 years of age showed epileptic activity, although she had had no clinical seizures.</Attribute>
              <Citation>
                <ID Source="PubMed">9603439</ID>
              </Citation>
              <XRef DB="OMIM" ID="256540" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTSA" />
          </GeneList>
          <Name>CTSA, 2-BP DEL, 517TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 517TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613111.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GALACTOSIALIDOSIS, LATE INFANTILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3418173" SubmissionDate="2023-05-17" DateLastUpdated="2023-06-03" DateCreated="2021-06-23">
        <ClinVarSubmissionID localKey="NM_000308.4:c.517_518delTT|MedGen:C0268233" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737781" DateUpdated="2023-06-03" DateCreated="2021-06-23" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28603679</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15110321</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10571006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29876240</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9603439</ID>
          </Citation>
          <Comment>Variant summary: CTSA c.517_518delTT/p.Phe173ProfsX39 (also known as c.569_570delTT) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251484 control chromosomes. c.517_518delTT has been reported in the literature in individuals affected with Galactosialidosis (e.g. Richard_1998, Okulu_2017). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in &lt;10% of normal activity (Richard_1998). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTSA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000308.4:c.517_518delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268233" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13370974</SubmissionName>
          <SubmissionName>SUB9873253</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9057067" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="74243818|Orphanet:ORPHA351" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848045" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9603439</ID>
          </Citation>
          <Comment>The p.Phe191ProfsX39 variant in CTSA has been reported in 1 individual (compound heterozygous) with clinical features of galactosialidosis-late infantile type (Richard 1998) and was absent from large population studies. However, these types of assays may not accurately represent biological function. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 191 and leads to a premature termination codon 39 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In vitro functional studies support that the p.Phe191ProfsX39 variant impacts protein function (Richard 1998). In summary, this variant meets criteria to be classified as pathogenic for galactosialidosis in an autosomal recessive manner based upon case studies, absence from controls and functional evidence.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTSA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000308.4:exon 6</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.11:g.45892797_45892798delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA351" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9057067" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA351" MappingRef="Orphanet">
        <MedGen CUI="C0268233" Name="Combined deficiency of sialidase AND beta galactosidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3418173" TraitType="Disease" MappingType="XRef" MappingValue="C0268233" MappingRef="MedGen">
        <MedGen CUI="C0268233" Name="Combined deficiency of sialidase AND beta galactosidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20562" TraitType="Disease" MappingType="Name" MappingValue="GALACTOSIALIDOSIS, LATE INFANTILE" MappingRef="Preferred">
        <MedGen CUI="C4017292" Name="Galactosialidosis, late infantile" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>